Professional development of pharmaceutical care in type 2 diabetes mellitus: A multidisciplinary conceptual model

International Journal of Pharmacy Practice

Volumn 14, Issue 4, 2006, Pages 289-299

  Power, Ailsa ^a   Douglas, Elizabeth ^b   Mc Gregor, Anna Marie ^c   Hudson, Steve ^b  

^a NHS EDUCATION FOR SCOTLAND   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c Scottish Executive   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMMUNITY CARE; CONTINUING EDUCATION; CONTROLLED STUDY; DIABETIC PATIENT; HEALTH CARE PERSONNEL; HUMAN; MEDICAL EDUCATION; MEDICAL PRACTICE; MEDICAL RESEARCH; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PATIENT EDUCATION; PATIENT MONITORING; PHARMACEUTICAL CARE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED KINGDOM;

EID: 33845955673     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1211/ijpp.14.4.0010     Document Type: Article

References (39)

1. Scottish Executive Health Department, Diabetes in Scotland. Current challenges and future opportunities - reviewing the Scottish Diabetes Framework. Edinburgh: The Stationery Office; 2004.
2. Scottish Executive Health Department. Scottish Diabetes Framework. Edinburgh: The Stationery Office; 2002.
3. Wagner EH. The role of patient care teams in chronic disease management. BMJ 2000;320:569-72.
4. A National Framework for Service Change in the NHS in Scotland. Edinburgh: Scottish Executive Health Department; 2005.
5. Bellingham C. Introducing the new Scottish contract. Pharm J 2005;275:637.
6. Cranor CW, Christensen DB. The Asheville Project: factors associated with outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc 2003;43:160-72.
7. Garrett DG, Martin LA. The Ashville Project: participants' perceptions of factors contributing to the success of a patient self-management diabetes program. J Am Pharm Assoc 2003;43:185-90.
8. Cranor CW, Christensen DB. The Ashville Project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc 2003;43:149-59.
9. Cranor CW, Bunting BA, Christensen DB. The Ashville Project: long-term clinical outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc 2003;43:173-84.
10. Jaber LA, Halapy, Fernet M, Tummalapalli S, Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother 1996;30:238-43.
11. Berringer R, Shibley MCH, Cary CC et al. Outcomes of a community pharmacy-based diabetes monitoring program. J Am Pharm Assoc 1999;39:791-7.
12. Coast-Senior EA, Kroner BA, Kelley CL, Trilli LE. Management of patients with type 2 diabetes by pharmacists in primary care clinics. Ann Pharmacother 1998;32:636-41.
13. Wermeille J, Bennie M, Brown I, McKnight J. Pharmaceutical care model for patients with type 2 diabetes: integration of the community pharmacist into the diabetes team - a pilot study. Pharm World Sci 2004;26:18-25.
14. Douglas E, Power A, Hudson SA. Pharmaceutical care of the patient with diabetes mellitus: pharmacists' priorities for services and educational needs in Scotland. Int J Pharm Pract (in press).
15. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
16. Scottish Executive. The right medicine: a strategy for pharmaceutical care in Scotland. Edinburgh: NHS Scotland; 2002.
17. Wagner EH, Grothaus LC, Sandhu N et al. Chronic care clinics for diabetes in primary care: a system-wide randomized trial. Diabetes Care 2001;24:695-700.
18. Munroe WP, Kunz K, Dalmady-Israel C, Potter L, Schonfeld WH. Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting. Clin Ther 1997;19:113-23.
19. Sadur CN, Moline N, Costa M et al. Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits. Diabetes Care 1999;22:2011-17.
20. Nichols-English G, Poirier S. Optimizing adherence to pharmaceutical care plans. J Am Pharm Assoc 2000;40:475-85.
21. Raji A, Gomes H, Beard J, MacDonald P, Conlin PR. A randomized trial comparing intensive and passive education in patients with diabetes mellitus. Arch Intern Med 2002;162:1301-4.
22. Fornos PJA, Andres RNF, Guerra GMM. Design and validation of a knowledge questionnaire regarding diabetes among patients attending a community pharmacy office. Pharm Care Espana 2003;5:268-74.
23. Abduelkarem AR, Sackville MA, Morgan RM, Sackville MP, Hildreth AJ. Views and practices of community pharmacists regarding services for people with type 2 diabetes. Nt J Pharm Pract 2003;11:161-8.
24. Berringer R, Shibley MC, Cary CC et al. Outcomes of a community pharmacy-based diabetes monitoring program. J Am Pharm Assoc 1999;39:791-7.
25. Brown CM, Green AL. Expectations of patients with diabetes for pharmaceutical care activities in community pharmacy settings. J Soc Admin Pharm 2000;17:219-23.
26. Clifford RM, Batty KT, Davis TME et al. Randomised controlled trial of a pharmaceutical care programme in high-risk diabetic patients in an outpatient clinic. Int J Pharm Pract 2002;10:85-9.
27. Tsuyuki RT, Johnson JA, Teo KK étal. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Interven-tion by Pharmacists (SCRIP). Arch Intern Med 2002;162: 1149-55.
28. Pizzi LT, Menz JM, Graber GR, Sun DC. From product dis-pensing to patient care: the role of the pharmacist in providing pharmaceutical care as part of an integrated disease manage-ment approach. Dis Manag 2001;4:143-54.
29. Scottish Diabetes Survey 2003, Edinburgh: Scottish Executive Health Department; 2004.
30. Ritchie J, Spencer L. Qualitative data analysis for applied pol-icy research. In: Bryman A, Burgess R, editors. Analysing qual-itative data. London: Routledge, 1993. pp 173-94.
31. Field PA, Morse JM. Nursing research: the application of quali-tative approaches. London: Chapman & Hall; 1989. 32 Mays N, Pope C. Rigour and qualitative research. BMJ 1995;311:109-12.
32. Walshe K, Benson L. Time for radical reform. BMJ 2005;330:1504-6.
33. Younis WS, Campbell S, Slack MK. Pharmacists' attitudes toward diabetes and their involvement in diabetes education. Ann Pharmacother 2001;35:841-5.
34. Gutierres SL, Welty TE. Point-of-care testing: an introduction. Ann Pharmacother 2004;38:119-25.
35. Armor BL, Britton ML. Diabetes mellitus non-glucose monitoring: point of care testing. Ann Pharmacother 2004;38: 1039-47.
36. Maintaining competency in prescribing: an outline framework to help pharmacist supplementary prescribing. Liverpool: National Prescribing Centre; 2003.
37. Paes AHP, Bakker A, Soe-Agnie CJ. Impact of dosage frequency on patient compliance. Diabetes Care 1997;20:1512-17.
38. Mino-Leon D, Figueras A, Amato D, Laporte JR. Treatment of type 2 diabetes in primary care: A drug utilization study. Ann Pharmacother 2005;39:441-5.
39. Schapansky LM, Johnson JA. Pharmacists' attitudes towards diabetes. J Am Pharm Assoc 2000;40:371-7.